Plunkett Research Online: Oasmia Pharmaceutical

OASMIA PHARMACEUTICAL (OASMY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology. The company produces novel formulations of well-established cytostatic agents which show improved performance, an im.....



Oasmia Pharmaceutical
Ticker: OASMY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 46 18505440
Fax: 46 18510873
Address: Vallongatan 1
Uppsala, SE-752 28 Sweden

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology. The company produces novel formulations of well-established cytostatic agents which show improved performance, an im.....See More See More

Auditor: KPMG AB
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (SEK) Bonus (SEK)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: